Ascend Wellness Holdings (AAWH) Cash from Financing Activities (2020 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Cash from Financing Activities of -$592000.0 in Q1 2026, up 48.48% quarter-over-quarter from -$1.1 million in Q4 2025, and down 104.32% on a YoY basis from $13.7 million in Q1 2025.
Ascend Wellness Holdings (AAWH) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Cash from Financing Activities history runs 7 years deep, the most recent figure standing at -$592000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 104.32% year-over-year to -$592000.0; the TTM figure through Mar 2026 stood at -$9.2 million (down 78.29% YoY), while the FY2025 annual figure was $5.1 million, up 125.09% from the prior year.
- Cash from Financing Activities was -$592000.0 for Q1 2026 at Ascend Wellness Holdings, up from -$1.1 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $54.7 million in Q2 2022 to a low of -$14.0 million in Q2 2025.
- Historically, Cash from Financing Activities has averaged $2.3 million across 5 years, with a median of -$1.1 million in 2025.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities jumped 1070.0% in 2022, then tumbled 6947.95% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at $18.5 million in 2022, then tumbled by 99.61% to $73000.0 in 2023, then sank by 6947.95% to -$5.0 million in 2024, then jumped by 77.02% to -$1.1 million in 2025, then jumped by 48.48% to -$592000.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$592000.0 (Q1 2026), -$1.1 million (Q4 2025), and $6.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -840.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1.48 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -86.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -65.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.47 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -77.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -11.62 Mn |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | -592,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -592,000.00 |
| Mar 31, 2026 | -592,000.00 |
| Dec 31, 2025 | -1.15 Mn |
| Dec 31, 2025 | -1.15 Mn |
| Sep 30, 2025 | 6.54 Mn |
| Sep 30, 2025 | 6.54 Mn |
| Jun 30, 2025 | -13.98 Mn |
| Jun 30, 2025 | -13.98 Mn |
| Mar 31, 2025 | 13.69 Mn |
| Mar 31, 2025 | 13.69 Mn |
| Dec 31, 2024 | -5.00 Mn |
| Dec 31, 2024 | -5.00 Mn |
| Sep 30, 2024 | -9.27 Mn |
| Sep 30, 2024 | -9.27 Mn |
| Jun 30, 2024 | -4.57 Mn |
| Jun 30, 2024 | -4.57 Mn |
| Mar 31, 2024 | -1.52 Mn |
| Mar 31, 2024 | -1.52 Mn |
| Dec 31, 2023 | 73,000.00 |
| Dec 31, 2023 | 73,000.00 |